Ȩ > Ç¥ÁØÈ °³¿ä > TTAÀÇ Ç¥ÁØÇöȲ
Ç¥ÁعøÈ£ | TTAK.KO-12.0381 | ±¸Ç¥ÁعøÈ£ | |
---|---|---|---|
Á¦°³Á¤ÀÏ | 2021-12-08 | ÃÑÆäÀÌÁö | 13 |
ÇѱÛÇ¥Áظí | ÀÇ·á±â±â ½ÃÆÇ ÈÄ »çÀ̹ö º¸¾È Ãë¾àÁ¡ ´ëÀÀ ÀýÂ÷ | ||
¿µ¹®Ç¥Áظí | Cybersecurity Vulnerabilities Countermeasuring Process for Medical Device Postmarket | ||
Çѱ۳»¿ë¿ä¾à | º» Ç¥ÁØÀº ÀÇ·á±â±â ½ÃÆÇ ÈÄ ¹ß»ýÇϰųª ¹ß»ýÇÒ ¼ö ÀÖ´Â »çÀ̹ö º¸¾È Ãë¾àÁ¡ ´ëÀÀÀ» À§ÇÑ ÀýÂ÷¸¦ ¸ð´ÏÅ͸µ, Ãë¾àÁ¡ °³¼±, Á¤º¸°øÀ¯, Áö¿ø Á¾·á ´Ü°è·Î ±¸ºÐÇÏ¿© ÀÇ·á±â±â Á¦Á¶»ç°¡ ÀÇ·á±â±â ½ÃÆÇ ÈÄ ¼öÇàÇØ¾ß ÇÏ´Â »çÀ̹ö º¸¾È Ãë¾àÁ¡ ´ëÀÀ È°µ¿À» Á¦½ÃÇÑ´Ù. | ||
¿µ¹®³»¿ë¿ä¾à | In order to respond to cybersecurity vulnerabilities that may occur in postmarket medical devices, this standard presents cybersecurity vulnerability response activities that medical device manufacturers should perform after marketing medical devices by categorizing them into monitoring, vulnerability remediation, information sharing, and end of support stages. | ||
±¹Á¦Ç¥ÁØ | |||
°ü·ÃÆÄÀÏ | TTAK.KO-12.0381.pdf |